CardiologyDr. Rohit GoelIschemic Heart Disease

Associate Director, Cardiology, Max Hospital, Gurugram

Part 4 of 10 in Diagnosis and Management of Ischemic Heart Disease

STEMI, Non-STEMI and Unstable Angina: How to Tell Them Apart

September 4, 2026

Dr. Rohit Goel summarized his entire diagnostic approach to acute coronary syndrome as a simple decision tree built on chest pain, the ECG and troponin, one that any referring doctor can run through at the bedside.

Start with the ECG

A patient with chest pain and ST elevation, or a new left bundle branch block, is diagnosed with STEMI and moves straight to reperfusion therapy, either thrombolysis or primary angioplasty depending on availability.

When the ECG shows something else

If there is chest pain but no ST elevation, only ST depression or T-wave inversion, the diagnosis depends on troponin: a positive troponin means non-ST-elevation MI, and a negative troponin with the same ECG picture means unstable angina.

Why the distinction changes treatment

Non-STEMI and unstable angina share the same medical treatment: aspirin, a P2Y12 inhibitor, a statin, a beta blocker and nitrates, plus heparin or low molecular weight heparin, with GP2b3a inhibitors reserved for high-risk patients. The one drug that separates STEMI treatment from the other two is thrombolysis, which is never given in non-STEMI or unstable angina and is reserved specifically for ST-elevation MI or new-onset left bundle branch block.

This article is based on a Jivo Masterclass session conducted by Dr. Rohit Goel, Principal Consultant, Cardiology, Max Hospital, Gurgaon. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a cardiology consultation or a second opinion on ischemic heart disease? Get in touch with the Jivo team

This guide is based on a live Jivo Masterclass — Dr. Rohit Goel taught doctors across Africa on June 1, 2025.

FROM THE LIVE Q&A

DR

Dr. Denawi

What is the approach for aortic dissection presenting like acute coronary syndrome?

RG

Dr. Rohit Goel

Management of aortic dissection depends on which part of the aorta is involved. If the dissection involves the ascending aorta or the arch, it needs surgical management. If it involves the descending thoracic aorta or the descending abdominal aorta, percutaneous repair of the aneurysm is possible instead.

See all 8 questions from this masterclass →

Book a Consultation with Dr. Rohit Goel

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

What is the lag time between the onset of symptoms and ST elevation on ECG?

Once symptoms begin, the earliest ST elevation can appear on ECG within 15 to 30 minutes. This ST elevation persists if there is complete occlusion of the artery, and can still be present up to 48 hours later. If blood flow is restored spontaneously, whether from medicines or other reasons, the ST elevation resolves; otherwise it persists until the artery is reopened.

What is the mortality rate for patients with ST-elevation MI?

Mortality in ST-elevation MI can be quite high if the patient is not treated properly, up to 30 to 50%, which is why adequate and timely treatment matters so much. Cardiac echo, alongside ECG and cardiac enzymes, is very important and can pick up early signs of heart damage; it is now one of the first-line investigations at tertiary care hospitals in suspected cases.

Is cardiac ultrasound of no importance in ischemic heart disease, and could you give a summary of its management?

Cardiac echo is important and is now done routinely, alongside cardiac enzymes and ECG, in suspected cases of heart attack at every tertiary care hospital where it is available. In summary, once ischemic heart disease is confirmed, every patient is loaded with aspirin (325 mg) along with clopidogrel (300 mg), prasugrel (60 mg) or ticagrelor (180 mg), a statin (atorvastatin or rosuvastatin, 40 to 80 mg), a beta blocker if blood pressure and heart rate allow, and glyceryl trinitrate for pain relief alongside oxygen. From there, ST-elevation MI patients receive heparin ahead of primary angioplasty, or are thrombolyzed if angioplasty is unavailable; non-ST-elevation MI and unstable angina patients are managed medically with low molecular weight heparin or fondaparinux instead of thrombolysis, and are escalated to coronary angiography and angioplasty or bypass surgery if they are high-risk or not improving.

Can myocardial bridging cause acute coronary syndrome, or can it be a risk factor?

Myocardial bridging can cause chest pain and can act as a risk factor. The initial approach is medical management with beta blockers, calcium channel blockers or nitrates. If the patient's chest pain continues despite medication, the next step is bypass surgery rather than angioplasty, since angioplasty is not successful in a bridged segment of artery.

What is the safety of these ACS drugs in pregnancy?

Aspirin, clopidogrel, statins and beta blockers are all safe in pregnancy and can be used without hesitation. Low molecular weight heparin is also safe. ACE inhibitors should not be given, and thrombolysis is contraindicated outright in pregnant patients; these patients should instead be referred for primary angioplasty. The mother's life takes priority, though the fetal risk should be explained to the family before proceeding.

What separates non-STEMI from unstable angina?

Both present with chest pain and similar ECG changes, but troponin is elevated in non-STEMI and normal in unstable angina.

Is thrombolysis ever used for non-STEMI?

No. Thrombolysis is reserved for ST-elevation MI or new-onset left bundle branch block. Non-STEMI and unstable angina are managed medically with heparin or low molecular weight heparin instead.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion